A group of pain researchers in Austria has lost their 2014 paper in the European Journal of Anaesthesiology because one of the authors wasn’t, well, one of the authors. The article, “Intravenous nonopioid analgesic drugs in chronic low back pain patients on chronic opioid treatment: A crossover, randomised, double-blinded, placebo-controlled study,” came from a team … Continue reading Pain paper scratched for authorship issues
This week at Retraction Watch featured retractions by a high-profile cancer researcher, and a loss in court for PubPeer. Here’s what was happening elsewhere:
We are pleased to present the first in a series of articles by John R. Thomas, Jr., a lawyer at Gentry Locke [Editor’s note, 3/26/19: He has since moved to Haley, Hafemann, Magee and Thomas] who represents whistleblowers in a variety of False Claims Act cases. He writes about how whistleblowers can do the right … Continue reading So you want to be a whistleblower? A lawyer explains the process
This week at Retraction Watch featured the retraction of yet another spoof article, and the temporary shutdown of a journal. Here’s what was happening elsewhere:
We’re pleased to introduce readers to Alice Dreger, a historian of science and medicine at the Medical Humanities and Bioethics Program in Northwestern University’s Feinberg School of Medicine. Her new book is “Galileo’s Middle Finger: Heretics, Activists, and the Search for Justice in Science,” out this week from Penguin Press. Read to the end for … Continue reading Yes, we are seeing more attacks on academic freedom: guest post by historian of science and medicine
Research director Alison Abritis earned her Ph.D. in Public Health, with a concentration in toxicology and risk assessment. Her dissertation focused on retractions and corrections, or the lack thereof, arising from misconduct findings by the Office of Research Integrity (ORI). She found that less than half of the findings resulted in a published retraction or correction, and even … Continue reading Meet the Retraction Watch staff
Drug researchers in India have lost their 2013 paper in ACS Medicinal Chemistry Letters because the first author fabricated findings. The article, by a group from the Maharaja Sayajirao University of Baroda, Vadodara, in Gujarat, was attempting to synthesize and screen novel clot-busting drugs; one compound exhibited the same activity as aspirin or warfarin, but … Continue reading Misconduct dissolves paper on possible clot-busters
The American Heart Association’s journal Circulation has issued an expression of concern for a paper about the molecular underpinnings of arrhythmias that was co-authored by a biomedical engineer who committed fraud on a massive scale. According to an investigation by the Office of Research Integrity (ORI), former Vanderbilt engineer Igor Dzhura faked nearly 70 images and drastically over-estimated … Continue reading Heart journal issues expression of concern after fraud report
This week at Retraction Watch featured a change of heart by a journal, and a look at Nature’s addition of double-blind peer review. Here’s what was happening elsewhere:
There are a number of fields that seem to punch above their weight on Retraction Watch: Anesthesiology, home to the world record holder (and runner-up), and psychology, home to Diederik Stapel and others. But the red-hot field of stem cell research is another that makes frequent appearances, last year’s STAP controversy being particularly prominent. There’s … Continue reading Are retractions more frequent in stem cell research?